Related Experiment Video
Updated: Sep 11, 2025

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.8K
Confounding factors affecting analysis of germline structural variants in pediatric solid tumors
Medrxiv : the Preprint Server for Health Sciences
|August 12, 2025
Summary
Germline predisposition structural variants in pediatric solid tumors may be misidentified due to tumor DNA contamination and ancestry biases. Future studies require rigorous analysis of contamination and population stratification for accurate clinical relevance.
Area of Science:
- Genetics
- Oncology
- Bioinformatics
Background:
- Germline structural variants (SV) are implicated in pediatric solid tumors.
- Previous studies reported SVs involving MYCN and RAF1::TMEM40.
- The clinical relevance of these findings requires validation.
Purpose of the Study:
- To investigate potential confounders in germline predisposition studies for pediatric solid tumors.
- To assess the impact of circulating tumor DNA (ctDNA) and population stratification on reported SVs.
- To provide recommendations for improving the accuracy of future germline studies.
Main Methods:
- Analysis of germline DNA samples from pediatric solid tumor cases.
- Assessment of tumor-in-normal contamination using non-polymorphic markers.
- Examination of population stratification using polymorphic markers.
- Bioinformatic analysis of SVs involving MYCN and RAF1::TMEM40.
Main Results:
- Germline predisposition SVs involving MYCN were confounded by ctDNA.
- Germline predisposition SVs involving RAF1::TMEM40 were confounded by enrichment for Hispanic or Latino ancestry.
- These confounders impact the reliability of reported germline findings.
Conclusions:
- Circulating tumor DNA and population stratification can lead to false positives in germline predisposition studies.
- Future germline studies must rigorously control for tumor contamination and population structure.
- Ensuring clinical relevance requires careful methodological validation in genetic studies of pediatric cancers.

